Volume 16, Issue 6 (Jun 2018)                   IJRM 2018, 16(6): 417-420 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yousefi Z, Khalilifar H, Jafarian A H, Davachi B, Mousavi Seresh L, Babapour N, et al . Granulosa-cell tumor after ovarian stimulation: A case report. IJRM 2018; 16 (6) :417-420
URL: http://ijrm.ir/article-1-1138-en.html
1- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2- Kosar IVF Center, Mashhad, Iran
3- Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4- Department of Radiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
5- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
6- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , sabalanmountain@yahoo.com
Abstract:   (5364 Views)
Background: Ovarian superovulation and increased follicle-stimulating hormone concentration for infertility treatment may be the risk factors of developed granulosa-cell tumor. The aim of this report is to introduce a case of granulosa-cell tumor which was discovered after ovarian stimulation.
Case: A 31-yr-old woman with clinical presentation of massive abdominal distention was referred to the gynecology and oncology department of an academic hospital, Mashhad University of Medical Sciences in Aug 2017. She had the history of secondary infertility and was undergoing In Vitro Fertilization protocol and ovarian stimulation, but, the cycle was canceled. The patient suffered from gradual abdominal distention one month after the end of IVF procedure despite pregnancy failure. 2-3 months after management of the ovarian hyperstimulation syndrome, investigation revealed large ovarian mass and increased tumor marker inhibin. Exploratory laparotomy was performed and revealed stage III ovarian cancer. The final pathology report indicated juvenile granulosa cell tumor. So, optimal surgical staging and cytoreductive surgery without fertility preserving were perfumed. Chemotherapy was recommended due to the advanced stage of ovarian cancer. Unfortunately, she experienced metastatic diseases in pelvic and abdomen in less than six months; and currently is receiving the second and third line chemotherapy.
Conclusion: Persistent ovarian enlargement or ascites during or after infertility treatment should be carefully considered and managed
Full-Text [PDF 632 kb]   (1028 Downloads) |   |   Full-Text (HTML)  (321 Views)  
Type of Study: Short Research Reports |

References
1. Göcze P, Krommer K, Csermely T, Cziráky K, Garamvölgyi Z, Kovács K, et al. Ovulation induction therapy and malignant ovarian cancer. Orv Hetil 2000; 141: 71-75.
2. Iavazzo C, Gkegkes ID, Vrachnis N. Fertility sparing management and pregnancy in patients with granulosa cell tumour of the ovaries. J Obstet Gynaecol 2015; 35: 331-355. [DOI:10.3109/01443615.2014.968107] [PMID]
3. Wu H, Pangas SA, Eldin KW, Patel KR, Hicks J, Dietrich JE, et al. Juvenile granulosa cell tumor of the ovary: A clinicopathologic study. J Pediatr Adolesc Gynecol 2017; 30: 138-143. [DOI:10.1016/j.jpag.2016.09.008] [PMID]
4. Mangili G, Ottolina J, Cormio G, Loizzi V, De Iaco P, Pellegrini DA, et al. Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study. Gynecol Oncol 2016; 143: 276-280. [DOI:10.1016/j.ygyno.2016.08.316] [PMID]
5. Färkkilä A, McConechy MK, Yang W, Talhouk A, Ng Y, Lum A, et al. FOXL2 402C>G mutation can Be identified in the circulating tumor DNA of patients with adult-type granulosa cell tumor. J Mol Diagn 2017; 19: 126-136. [DOI:10.1016/j.jmoldx.2016.08.005] [PMID]
6. Foulkes WD, Gore M, McCluggage WG. Rare non-epithelial ovarian neoplasms: pathology, genetics and treatment. Gynecol Oncol 2016; 142: 190-198. [DOI:10.1016/j.ygyno.2016.04.005] [PMID]
7. Söderström HF, Carlsson A, Börjesson A, Elfving M. Vaginal bleeding in prepubertal girls: etiology and clinical management. J Pediatr Adolesc Gynecol 2016; 29: 280-285. [DOI:10.1016/j.jpag.2015.10.017] [PMID]
8. Ghribi A, Bouden A, Gasmi M, Hamzaoui M. Unusual malignant neoplasms of ovary in children: two cases report. Korean J Pediatr 2016; 59 (Suppl.): S107-S111. [DOI:10.3345/kjp.2016.59.11.S107] [PMID] [PMCID]
9. Hill BJ, Morrell TJ, Zhang MM, Norian JM. Utility of antimüllerian hormone level obtained for infertility assessment for alerting to ovarian tumor. Obstet Gynecol 2013; 121 (Suppl.): 454-457.
10. Ashnagar A, Alavi S, Nilipour Y, Azma R, Falahati F. Massive ascites as the only sign of ovarian juvenile granulosa cell tumor in an adolescent: a case report and a review of the literature. Case Rep Oncol Med 2013; 2013: 386725. [DOI:10.1155/2013/386725] [PMID] [PMCID]
11. Bryk S, Pukkala E, Martinsen JI, Unkila-Kallio L, Tryggvadottir L, Sparén P, et al. Incidence and occupational variation of ovarian granulosa cell tumors in Finland, Iceland, Norway and Sweden during 1953-2012: a longitudinal cohort study. BJOG 2017; 124: 143-149. [DOI:10.1111/1471-0528.13949] [PMID]
12. Bryk S, Färkkilä A, Bützow R, Leminen A, Heikinheimo M, Anttonen M, et al. Clinical characteristics and survival of patients with an adult-type ovarian granulosa cell tumor: a 56-year single-center experience. Int J Gynecol Cancer 2015; 25: 33-41. [DOI:10.1097/IGC.0000000000000304] [PMID]
13. McConechy MK, Färkkilä A, Horlings HM, Talhouk A, Unkila-Kallio L, van Meurs HS, et al. Molecularly defined adult granulosa cell tumor of the ovary: the clinical phenotype. J Natl Cancer Inst 2016; 108: 1-5. [DOI:10.1093/jnci/djw134] [PMID] [PMCID]
14. Lee IH, Choi CH, Hong DG, Song JY, Kim YJ, Kim KT, et al. Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol 2011; 22: 188-195. [DOI:10.3802/jgo.2011.22.3.188] [PMID] [PMCID]
15. Jamieson S, Fuller PJ. Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev 2012; 33: 109-144. [DOI:10.1210/er.2011-0014] [PMID]
16. Diergaarde B, Kurta ML. Use of fertility drugs and risk of ovarian cancer. Curr Opin Obstet Gynecol 2014; 26: 125-129. [DOI:10.1097/GCO.0000000000000060] [PMID] [PMCID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb